Skip to main content

Resource Download
How Does the Biden Administration Want to ‘Take on Pharma?’

  • Democratic President-elect Joe Biden and his administration are poised to take the reins from President Donald Trump, who had just begun to more stringently address prescription drug prices in the U.S. via Executive Orders (EOs) aimed at introducing an American version of reference pricing.
  • Throughout his campaign, Biden has promised to expand access to health care through the “BidenPlan,” an evolution of former President Barack Obama’s Affordable Care Act, dubbed “Obamacare,”while “taking on big pharma” and reining in “runaway” drug prices.
  • Biden has also announced intentions to set up a government-run, Institute for Clinical and Economic Review (ICER) -style Health Technology Assessment (HTA) body, as ICER is currently an autonomous body to the U.S. government

Download your copy

EPP Pricing Platform will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy page.